SARS-CoV-2 Monoclonal Antibodies in Children: Ethical Considerations
This article identifies, analyzes, and makes recommendations on the methods by which health systems, hospitals, and individual clinicians can ethically balance these tensions. (Clin Ther. 2021;43:XXX-XXX) © 2021 Elsevier Inc.PMID:34049725 | DOI:10.1016/j.clinthera.2021.04.008
Source: Clinical Therapeutics - Category: Drugs & Pharmacology Authors: Ian D Wolfe Sameer J Patel Source Type: research
More News: Children | COVID-19 | Drugs & Pharmacology | Emergency Medicine | Food and Drug Administration (FDA) | Hospitals | Medical Ethics | SARS